Clinical news 25/01/2025
As we enter 2025, we are proud to announce that TBS Osteo is trusted by more of the United States’ leading hospitals than ever before. Beyond its presence in all U.S. states and worldwide, along with its growing adoption in clinical routines, TBS Osteo is now present in 16 of the 20 hospitals ranked on the U.S. News Best Hospitals Honor Roll for 2024-2025.
The expanded adoption of TBS Osteo among leading healthcare institutions in the US underscores a pivotal shift in bone health assessment. By moving beyond traditional bone mineral density (BMD) measurements, these hospitals recognize the essential role of assessing the bone’s microarchitecture through TBS, which captures a more comprehensive view of bone quality and help enhances diagnostic accuracy. This evolution represents not only an innovation in bone health but a meaningful step toward personalized and patient-centered care.
Incorporating TBS Osteo into clinical routines has enabled clinicians to adopt a holistic approach to bone health, shifting away from the conventional, one-size-fits-all model. Now, with TBS Osteo, clinicians are empowered to make more tailored decisions in managing and treating bone health, improving patient outcomes through insights that go beyond bone density alone.
TBS continues its expansion into the U.S. News Best Hospitals Honor Roll for 2024-2025, reflecting its broad adoption by the most respected medical centers in the world. This expansion is a testament to the importance of Trabecular Bone Score (TBS) into the diagnosis of osteoporosis, which affects 50% of women over the age of 50. Complementing current diagnosis protocols, TBS enables to detect 30% more patients at risk, triggering a preventive approach of this common disease.
